A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection

NCT02292719 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C Virus Infection

Interventions

DRUG: OBV/PTV/r
DRUG: Sofosbuvir
DRUG: Ribavirin (RBV)

Sponsor

AbbVie